Emergency Contraceptive Pills Market 2022 Industry Trends, Sales, Supply, Demand, Analysis & Forecast to 2025

Posted on 2022-04-15 by Future Market Insights, Inc in Healthcare, Pharmaceuticals // 0 Comments

New York, United States, 2022-Apr-15 — /EPR Network/ —

Emergency Contraceptive Pills Market 2022

Emergency Contraceptive Pills Market is likely to grow voraciously, i.e. at a CAGR of 3% between 2022-2025, reaching US$ 1,230 Mn. Augmented and virtual reality are abreast with advanced technologies on a significant count. VR and AR do have loads of potential for offering in the healthcare vertical. The application areas include surgery and training simulation, and patients care and treatment.

Click Here to Get Free Sample Copy of This Report@https://www.persistencemarketresearch.com/samples/18343

The report has also profiled leading players in the global market for emergency contraceptive pills, which includes companies namely, Teva Pharmaceutical Industries Ltd., Bayer AG, HRA Pharma, Piramal Enterprises Limited, Mankind Pharma Ltd., Richter Gedeon Nyrt, Lupin Limited, Cooper Pharma, Pfizer Inc., and Zhejiang Xianju Pharmaceutical Co.

Negative perceptions about emergency contraception are likely to hamper the sales of “morning after” pills in the future. Despite the high accessibility of emergency contraceptive pills, followed by rising awareness of highly-effective birth control methods, incidences of unwanted or mistimed pregnancies persist. Moreover, high risk of morbidity and mortality associated with these pregnancies is disintegrating the fabric of urban cultures.

While unprotected sex continues to be a matter of mutual consent, obstetricians advise couples to opt for emergency contraception, particularly in healthcare settings with lack of accessibility to proper & safe abortion. Since unprotected sex also increases the risks of sexually transmitted infections, the ineffectiveness of emergency contraceptive pills in protection from venereal diseases continues to be a concern for manufacturers. Sales of emergency contraceptive pills are also being adversely impacted by unresolved side effects of emergency contraception – which include time constraint for intake, heavy vomiting, muscle spasms, and feeling nauseous.

According to Persistence Market Research’s newly-published study, the global sales of emergency contraceptive pills are expected to dwindle in the next five years. By the end of 2025, the global market for emergency contraceptive pills will have reached a value of just over US$ 1,230 Mn. During the forecast period, 2017-2025, the global emergency contraceptive pill market is anticipated to exhibit sluggish growth and reflect less than 3% CAGR.

Request For Customization@https://www.persistencemarketresearch.com/request-customization/18343

Combination Pills showcase promising growth potential

The report segments the global market for emergency contraceptive pills on the basis of products, among which combination pills are expected to dominate the market revenues. In the foreseeable future, combination pills will witness relatively higher sales in the global market, primarily due to their health benefits in reducing risk of ectopic pregnancy. In 2017, nearly two-fifth of revenues procured in the global emergency contraceptive pills market will be contributed by global sales of combination pills.

On the contrary, use of estrogen pills for emergency contraception will lose traction. Over the forecast period, estrogen pills as a product in the global emergency contraceptive pills market will exhibit revenue growth at just 1.5% CAGR. Demand for progesterone pills is also expected to drop, particularly owing to their side effects which include joint pain, hot flashes, and diarrhea.

Online Traders will reflect low sales growth

Key findings from the report indicate drug stores and hospital pharmacies as the two largest sales channels for emergency contraceptive pills. In 2017, sales of emergency contraceptive pills through these channels is expected to account for collective global revenue share of nearly 70%. Online sales of emergency contraceptive pills will incur a considerable decline, and procure not more than US$ 160 Mn in global revenues by the end of 2022.

The report also identifies North America as the largest market for emergency contraceptive pills. The International Consortium for Emergency Contraception is based in the US and serves the mission of expanding access to safe and appropriate use of emergency contraception products.

Click Here to Get Full Report@https://www.persistencemarketresearch.com/checkout/18343

Emergency Contraceptive Pills Market – Report Highlights

A detailed overview of parent market of Emergency Contraceptive Pills Market
Changing Emergency Contraceptive Pills Market dynamics in the industry
In-depth segmentation of the Emergency Contraceptive Pills Market
Historical, current, and projected Emergency Contraceptive Pills Market size regarding volume and value
Recent industry trends and developments in Emergency Contraceptive Pills Market
Competitive landscape of the Emergency Contraceptive Pills Market
Strategies for key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on Emergency Contraceptive Pills Market performance
Must-have information for Emergency Contraceptive Pills Market players to sustain and enhance their market footprint

About PersistenceMarketResearch:

PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.

Matched content

Editor’s pick